Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study-Reference-Cited by-同舟云学术

Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study

Published:2022-04 Issue: Volume:165 Page:13-24
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ladoire Sylvain^ORCID,Rederstorff Emilie,Goussot Vincent^ORCID,Parnalland Sophie,Briot Nathalie,Ballot Elise,Truntzer Caroline^ORCID,Ayati Siavoshe,Bengrine-Lefevre Leila,Bremaud Nathalie,Coudert Bruno^ORCID,Desmoulins Isabelle,Favier Laure,Fraisse Cléa,Fumet Jean-David,Hennequin Audrey,Hervieu Alice,Ilie Silvia,Kaderbhai Courèche,Lagrange Aurélie,Martin Nils,Mazilu Irina,Mayeur Didier,Palmier Rémi,Simonet-Lamm Anne-Laure,Vincent Julie,Zanetta Sylvie^ORCID,Arnould Laurent,Coutant Charles,Bertaut Aurélie,Ghiringhelli François

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. A novel coronavirus from patients with Pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis;Tsang;Lancet Infect Dis,2021

3. Humoral immune response to SARS-CoV-2 in Iceland;Gudbjartsson;N Engl J Med,2020

4. Assessing the extent of SARS-CoV-2 circulation through serological studies;Koopmans;Nat Med,2020

5. Identification of RT-PCR-negative asymptomatic COVID-19 patients via serological testing;Wu;Front Public Health,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2;Acta Oncologica;2023-09-20

2. One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study;International Journal of Environmental Research and Public Health;2023-05-25

3. Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave;Cancers;2022-09-23